237 related articles for article (PubMed ID: 18253111)
21. Prostatic disease: a rational approach.
Simpson RJ
Practitioner; 1998 Sep; 242(1590):638-40, 642, 644. PubMed ID: 10534880
[No Abstract] [Full Text] [Related]
22. [Influence of dihydrotestosterone deficit on treatment of prostatic diseases regarding to contemporary methods of prostatic hypertrophy treatments].
Laszczyńska M; Chorzepa-Nowicka K; Wylot M; Piasecka M; Gaczarzewicz D
Pol Merkur Lekarski; 2008 Dec; 25(150):528-30. PubMed ID: 19205388
[TBL] [Abstract][Full Text] [Related]
23. [Dutasteride--an inhibitor of 5alpha-reductase of type I and II--in the treatment of patients with prostatic adenoma. What is the latest news?].
Grigor'ev ME; Konorev VA
Urologiia; 2007; (6):90, 92-5. PubMed ID: 18652016
[No Abstract] [Full Text] [Related]
24. Medical management of lower urinary tract symptoms in men: current treatment and future approaches.
Patel AK; Chapple CR
Nat Clin Pract Urol; 2008 Apr; 5(4):211-9. PubMed ID: 18301417
[TBL] [Abstract][Full Text] [Related]
25. [Severe hematuria caused by radiation cystitis. Selective percutaneous embolization as an alternative therapy].
Ferrer Puchol MD; Borrel Palanca A; Gil Romero J; Pallardo Calatayud Y; Cervera de Val V; Laso Pablos MS; Nogues Pelayo E
Actas Urol Esp; 1998 Jun; 22(6):519-23. PubMed ID: 9734131
[TBL] [Abstract][Full Text] [Related]
26. Canine prostatic disease: a review of anatomy, pathology, diagnosis, and treatment.
Smith J
Theriogenology; 2008 Aug; 70(3):375-83. PubMed ID: 18514299
[TBL] [Abstract][Full Text] [Related]
27. Benign prostatic hyperplasia--review of treatment options.
Oehlke KJ; Branaugh ML
S D Med; 2009 May; 62(5):202-3. PubMed ID: 19489345
[No Abstract] [Full Text] [Related]
28. A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits.
Montorsi F; Alcaraz A; Desgrandchamps F; Hammerer P; Schröder F; Castro R
Prostate; 2009 Jun; 69(8):895-907. PubMed ID: 19267353
[TBL] [Abstract][Full Text] [Related]
29. [Diseases of the prostate, their diagnosis and therapy at the present time].
Geisthövel W
Dtsch Med J; 1966 Jul; 17(14):423-6. PubMed ID: 4169216
[No Abstract] [Full Text] [Related]
30. Pharmacological approaches to reducing the risk of prostate cancer.
Rittmaster RS; Fleshner NE; Thompson IM
Eur Urol; 2009 May; 55(5):1064-73. PubMed ID: 19200641
[TBL] [Abstract][Full Text] [Related]
31. Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5alpha-reductase.
Vis AN; Schröder FH
BJU Int; 2009 Nov; 104(9):1191-7. PubMed ID: 19624596
[TBL] [Abstract][Full Text] [Related]
32. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R
Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
[TBL] [Abstract][Full Text] [Related]
33. Management of benign prostatic hyperplasia by the primary care physician in the 21st century: the new paradigm.
Barkin J
Can J Urol; 2008 Aug; 15 Suppl 1():21-30; discussion 30. PubMed ID: 18700062
[TBL] [Abstract][Full Text] [Related]
34. [The experience in dutasteride use before transurethral prostatic resection for large adenoma].
Martov AG; Ergakov DV
Urologiia; 2008; (4):46, 48-50, 52. PubMed ID: 19054996
[TBL] [Abstract][Full Text] [Related]
35. The diagnosis of hematuria.
Abuelo JG
Arch Intern Med; 1983 May; 143(5):967-70. PubMed ID: 6206812
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and survival associated with cystoscopy and clot evacuation for radiation or cyclophosphamide induced hemorrhagic cystitis.
Kaplan JR; Wolf JS
J Urol; 2009 Feb; 181(2):641-6. PubMed ID: 19091348
[TBL] [Abstract][Full Text] [Related]
37. Transradial Prostatic Artery Embolization as a Salvage Procedure in a Patient With Severe Deformities and Refractory Hematuria of Prostatic Origin.
Moschouris H; Tsetsou I; Kaniaris A; Stamatiou K
Cureus; 2024 May; 16(5):e59894. PubMed ID: 38854172
[TBL] [Abstract][Full Text] [Related]
38. Selective renal embolization for hematuria: coordination with cystoscopy.
Swartz DA; McLellan GL; Mitchum D; Vines F
AJR Am J Roentgenol; 1988 Feb; 150(2):325-6. PubMed ID: 3257318
[No Abstract] [Full Text] [Related]
39. Benign prostatic hyperplasia.
Cygan R; Rucker L
West J Med; 1984 Oct; 141(4):528-30. PubMed ID: 6506690
[No Abstract] [Full Text] [Related]
40. Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia.
Nichol MB; Knight TK; Wu J; Barron R; Penson DF
J Urol; 2009 May; 181(5):2214-21; discussion 2221-2. PubMed ID: 19296986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
